An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses
Many types of microneedle (MN) arrays have been tested for delivery of vaccines to the skin. However, the effect of MN geometry/array design on antibody production is still unclear. Reports suggest that systemic immune responses may be affected by how MN arrays “mechanically” deliver vaccines, which...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2022-08-01
|
| Series: | Advanced NanoBiomed Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/anbr.202100151 |
| _version_ | 1811216884414021632 |
|---|---|
| author | Jacob W. Coffey Nicole M. D. van der Burg Thippayawan Rananakomol Hwee-Ing Ng Germain J. P. Fernando Mark A. F. Kendall |
| author_facet | Jacob W. Coffey Nicole M. D. van der Burg Thippayawan Rananakomol Hwee-Ing Ng Germain J. P. Fernando Mark A. F. Kendall |
| author_sort | Jacob W. Coffey |
| collection | DOAJ |
| description | Many types of microneedle (MN) arrays have been tested for delivery of vaccines to the skin. However, the effect of MN geometry/array design on antibody production is still unclear. Reports suggest that systemic immune responses may be affected by how MN arrays “mechanically” deliver vaccines, which can induce cell damage and act as an adjuvant. This includes parameters such as MN length/insertion depth, delivery energy/velocity, MN shape, and density. However, these effects have not been systematically investigated. Herein, the effect of MN density on antibody responses to influenza vaccination is assessed, keeping all other variables constant. MN arrays are manufactured within the “high‐density range” from 5 k microneedles cm−2 (n cm−2) to the “ultrahigh” 30 k n cm−2. Prior to this study, the highest MN density used for vaccination is 20 k n cm−2. Thus, MN array vaccination is evaluated over an unprecedented range. Cell viability is assessed in the skin after application and antibody responses at days 21/63. It is demonstrated that increasing MN density from 5 to 30 k n cm−2 increases both epidermal cell death and anti‐influenza IgG1, without an increase in anti‐influenza IgG2a. This suggests that MN density has a direct adjuvant effect on immune responses through Th2‐mediated signalling—a response critical for human vaccination. |
| first_indexed | 2024-04-12T06:45:07Z |
| format | Article |
| id | doaj.art-c1b1cfcd169e43cba45a1a892c3690cb |
| institution | Directory Open Access Journal |
| issn | 2699-9307 |
| language | English |
| last_indexed | 2024-04-12T06:45:07Z |
| publishDate | 2022-08-01 |
| publisher | Wiley-VCH |
| record_format | Article |
| series | Advanced NanoBiomed Research |
| spelling | doaj.art-c1b1cfcd169e43cba45a1a892c3690cb2022-12-22T03:43:36ZengWiley-VCHAdvanced NanoBiomed Research2699-93072022-08-0128n/an/a10.1002/anbr.202100151An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune ResponsesJacob W. Coffey0Nicole M. D. van der Burg1Thippayawan Rananakomol2Hwee-Ing Ng3Germain J. P. Fernando4Mark A. F. Kendall5The Delivery of Drugs and Genes Group (D2G) Australian Institute for Bioengineering and Nanotechnology University of Queensland St. Lucia QLD 4072 AustraliaThe Delivery of Drugs and Genes Group (D2G) Australian Institute for Bioengineering and Nanotechnology University of Queensland St. Lucia QLD 4072 AustraliaThe Delivery of Drugs and Genes Group (D2G) Australian Institute for Bioengineering and Nanotechnology University of Queensland St. Lucia QLD 4072 AustraliaThe Delivery of Drugs and Genes Group (D2G) Australian Institute for Bioengineering and Nanotechnology University of Queensland St. Lucia QLD 4072 AustraliaThe Delivery of Drugs and Genes Group (D2G) Australian Institute for Bioengineering and Nanotechnology University of Queensland St. Lucia QLD 4072 AustraliaThe Delivery of Drugs and Genes Group (D2G) Australian Institute for Bioengineering and Nanotechnology University of Queensland St. Lucia QLD 4072 AustraliaMany types of microneedle (MN) arrays have been tested for delivery of vaccines to the skin. However, the effect of MN geometry/array design on antibody production is still unclear. Reports suggest that systemic immune responses may be affected by how MN arrays “mechanically” deliver vaccines, which can induce cell damage and act as an adjuvant. This includes parameters such as MN length/insertion depth, delivery energy/velocity, MN shape, and density. However, these effects have not been systematically investigated. Herein, the effect of MN density on antibody responses to influenza vaccination is assessed, keeping all other variables constant. MN arrays are manufactured within the “high‐density range” from 5 k microneedles cm−2 (n cm−2) to the “ultrahigh” 30 k n cm−2. Prior to this study, the highest MN density used for vaccination is 20 k n cm−2. Thus, MN array vaccination is evaluated over an unprecedented range. Cell viability is assessed in the skin after application and antibody responses at days 21/63. It is demonstrated that increasing MN density from 5 to 30 k n cm−2 increases both epidermal cell death and anti‐influenza IgG1, without an increase in anti‐influenza IgG2a. This suggests that MN density has a direct adjuvant effect on immune responses through Th2‐mediated signalling—a response critical for human vaccination.https://doi.org/10.1002/anbr.202100151adjuvantantibody IgGcell deathdensitymicroneedlesskin vaccination |
| spellingShingle | Jacob W. Coffey Nicole M. D. van der Burg Thippayawan Rananakomol Hwee-Ing Ng Germain J. P. Fernando Mark A. F. Kendall An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses Advanced NanoBiomed Research adjuvant antibody IgG cell death density microneedles skin vaccination |
| title | An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses |
| title_full | An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses |
| title_fullStr | An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses |
| title_full_unstemmed | An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses |
| title_short | An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses |
| title_sort | ultrahigh density microneedle array for skin vaccination inducing epidermal cell death by increasing microneedle density enhances total igg and igg1 immune responses |
| topic | adjuvant antibody IgG cell death density microneedles skin vaccination |
| url | https://doi.org/10.1002/anbr.202100151 |
| work_keys_str_mv | AT jacobwcoffey anultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT nicolemdvanderburg anultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT thippayawanrananakomol anultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT hweeingng anultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT germainjpfernando anultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT markafkendall anultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT jacobwcoffey ultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT nicolemdvanderburg ultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT thippayawanrananakomol ultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT hweeingng ultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT germainjpfernando ultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses AT markafkendall ultrahighdensitymicroneedlearrayforskinvaccinationinducingepidermalcelldeathbyincreasingmicroneedledensityenhancestotaliggandigg1immuneresponses |